CTEV
HealthcareClaritev Corporation
$29.53
$-4.36 (-12.87%)
Jan 5, 2026
Price History (1Y)
Analysis
Claritev Corporation is a healthcare company specializing in health information services. Operating within the health information sector, Claritev has a significant scale with a market capitalization of $488.00 million and revenue of $951.00 million. The company's financial health reflects mixed results. Despite a gross margin of 74.7% and operating margin of 9.7%, Claritev reported a net loss of $341.67 million in the trailing twelve months. The return on equity (ROE) stands at -646.3%, indicating significant losses relative to shareholder equity. On the other hand, the company maintains a current ratio of 1.21 and has cash reserves of $39.15 million. The valuation context suggests that Claritev is trading at a price to sales ratio of 0.51 and an EV/EBITDA ratio of 9.93, indicating some level of undervaluation relative to its peers. The company's revenue growth rate stands at 6.7% year-over-year, although the earnings growth rate is not provided.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
Visit website →Key Statistics
- Market Cap
- $488.00M
- P/E Ratio
- N/A
- 52-Week High
- $74.07
- 52-Week Low
- $11.43
- Avg Volume
- 217.18K
- Beta
- 0.52
Company Info
- Industry
- Health Information Services
- Exchange
- NYQ
- Country
- United States
- Employees
- 2,700